{"id":"W4406870903","doi":"10.1200/jco.2025.43.4_suppl.575","title":"Outcomes by transarterial chemoembolization (TACE) modality from participants (pts) with embolization-eligible hepatocellular carcinoma (HCC) treated with durvalumab (D) + bevacizumab (B) + TACE and placebos (PBO) + TACE: EMERALD-1 subgroup analysis.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Bevacizumab; Oncology; Internal medicine; Embolization; Durvalumab; Refractory (planetary science); Subgroup analysis; Radiology; Cancer; Chemotherapy; Immunotherapy; Meta-analysis; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001634022,0.0008468159,0.001703371,0.0005641744,0.0002343728,0.0006414332,0.0003762426,0.000761113,0.002518273],"category_scores_gemma":[0.002276162,0.0003249671,0.006513181,0.0005712272,0.0002714899,0.0004324531,0.0007173701,0.00131326,0.0002680859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005593302,"about_ca_system_score_gemma":0.0008341562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001306049,"about_ca_topic_score_gemma":0.003102206,"domain_scores_codex":[0.9989687,0.0003667269,0.000198961,0.0002126877,0.0001241755,0.0001286756],"domain_scores_gemma":[0.9992408,0.0002549677,0.0002793146,0.00007087454,0.0000578561,0.00009621615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7225415,0.001872256,0.1090253,0.007174698,0.08735994,0.0005662523,0.0004395156,0.001557106,0.006368511,0.0003555506,0.006186303,0.05655305],"study_design_scores_gemma":[0.26252,0.1106569,0.4655048,0.001243065,0.1328445,0.001604,0.0007726248,0.004888314,0.00551135,0.002358098,0.01188701,0.0002094966],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827855,0.008383631,0.0006930553,0.000247366,0.0001593675,0.001093848,0.005282488,0.0000262342,0.001328404],"genre_scores_gemma":[0.9936015,0.001291609,0.0002636225,0.0002392638,0.0001115162,0.001158538,0.002561406,0.00000735319,0.0007651601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002518273,"threshold_uncertainty_score":0.008641601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08693050606015161,"score_gpt":0.3746808627175119,"score_spread":0.2877503566573603,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}